BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Diagnosis
39 results:

  • 1. Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021.
    Gill H; Raghupathy R; Lee CYY; Yung Y; Chu HT; Ni MY; Xiao X; Flores FP; Yim R; Lee P; Chin L; Li VWK; Au L; Au WY; Ma ESK; Mohan D; Kumana CR; Kwong YL
    BMC Cancer; 2023 Feb; 23(1):141. PubMed ID: 36765318
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer.
    Cheng E; Shi Q; Shields AF; Nixon AB; Shergill AP; Ma C; Guthrie KA; Couture F; Kuebler P; Kumar P; Tan B; Krishnamurthi SS; Ng K; O'Reilly EM; Brown JC; Philip PA; Caan BJ; Cespedes Feliciano EM; Meyerhardt JA
    JAMA Oncol; 2023 Mar; 9(3):404-413. PubMed ID: 36701146
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial.
    Burke GAA; Vinti L; Kabickova E; Beishuizen A; Tacyildiz N; Uyttebroeck A; Kang HJ; Luisi F; Minard-Colin V; Burkhardt B; Tamegnon M; Sun S; Curtis M; Deshpande S; Nottage K; Howes A; Srinivasan S; Bhojwani D; Norris R; Cairo M
    Blood Adv; 2023 Feb; 7(4):602-610. PubMed ID: 36541957
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Signaling factors potentially associated to the pathogenesis of Adult T-cell leukemia /lymphoma: A network-analysis and novel findings assessment.
    Mozhgani SH; Zarei Ghobadi M; Norouzi M; Rahimi H; Valizadeh N; Teymoori-Rad M; Tarokhian H; Ostadali M; Farajifard H; Rezaee SA
    Virus Res; 2022 Oct; 319():198875. PubMed ID: 35868352
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML.
    Martelli MP; Rossi R; Venanzi A; Meggendorfer M; Perriello VM; Martino G; Spinelli O; Ciurnelli R; Varasano E; Brunetti L; Ascani S; Quadalti C; Cardinali V; Mezzasoma F; Gionfriddo I; Milano F; Pacini R; Tabarrini A; Bigerna B; Albano F; Specchia G; Vetro C; Di Raimondo F; Annibali O; Avvisati G; Rambaldi A; Falzetti F; Tiacci E; Sportoletti P; Haferlach T; Haferlach C; Falini B
    Blood; 2021 Dec; 138(25):2696-2701. PubMed ID: 34343258
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay.
    Drieux F; Ruminy P; Abdel-Sater A; Lemonnier F; Viailly PJ; Fataccioli V; Marchand V; Bisig B; Letourneau A; Parrens M; Bossard C; Bruneau J; Dobay P; Veresezan L; Dupuy A; Pujals A; Robe C; Sako N; Copie-Bergman C; Delfau-Larue MH; Picquenot JM; Tilly H; Delarue R; Jardin F; de Leval L; Gaulard P
    Haematologica; 2020 Jun; 105(6):1582-1592. PubMed ID: 31488561
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical applicability of proposed algorithm for identifying individuals at risk for hereditary hematologic malignancies.
    Clifford M; Bannon S; Bednar EM; Czerwinski J; Davis J; Dunnington L; Shahrukh Hashmi S; DiNardo CD
    Leuk Lymphoma; 2019 Dec; 60(12):3020-3027. PubMed ID: 31274040
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Limited value of routine follow-up visits in chronic lymphocytic leukemia managed initially by watch and wait: A North Denmark population-based study.
    Nørgaard CH; Søgaard NB; Biccler JL; Pilgaard L; Eskesen MH; Kjartansdottir TH; Bøgsted M; El-Galaly TC
    PLoS One; 2018; 13(12):e0208180. PubMed ID: 30589850
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Distinct EphB4-mediated mechanisms of apoptotic and resistance to dasatinib in human chronic myeloid leukemia and K562 cell lines.
    Zhao WH; Huang BT; Zhang JY; Zeng QC
    Leuk Res; 2017 Dec; 63():28-33. PubMed ID: 29096333
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Clinical significance of cytogenetic monitoring in chronic myeloid leukemia].
    Pan CY; Xu N; He BL; Cao R; Liao LB; Yin CX; Lan YQ; Lu ZY; Huang JX; Sun J; Feng R; Liu QF; Liu XL
    Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):112-117. PubMed ID: 28279034
    [No Abstract]    [Full Text] [Related]  

  • 11. Evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors.
    Sivgin S; Karakus E; Keklik M; Zararsiz G; Solmaz M; Kaynar L; Eser B; Cetin M; Unal A
    Transfus Apher Sci; 2016 Jun; 54(3):410-5. PubMed ID: 27052362
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria.
    Weinberg OK; Seetharam M; Ren L; Alizadeh A; Arber DA
    Am J Clin Pathol; 2014 Dec; 142(6):803-8. PubMed ID: 25389334
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Homoharringtonine contributes to imatinib sensitivity by blocking the EphB4/rhoa pathway in chronic myeloid leukemia cell lines.
    Huang BT; Zeng QC; Zhao WH; Tan Y
    Med Oncol; 2014 Feb; 31(2):836. PubMed ID: 24415355
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Relationship between Spred1 and acute myeloid leukemia].
    Zhang Y; Li Y; Zhang R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1083-7. PubMed ID: 23998617
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia.
    DiNardo CD; Gharibyan V; Yang H; Wei Y; Pierce S; Kantarjian HM; Garcia-Manero G; Rytting M
    Am J Hematol; 2013 Sep; 88(9):784-9. PubMed ID: 23757320
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Detection of the expression of NK ligands in acute leukemia cell lines by real-time PCR].
    Luo Y; Duan LN; Lu CR; Cai Q; Wang Z; Bao RF; Xiang PD
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jan; 34(1):26-9. PubMed ID: 23597460
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Novel real-time simultaneous amplification and testing method to accurately and rapidly detect Mycobacterium tuberculosis complex.
    Cui Z; Wang Y; Fang L; Zheng R; Huang X; Liu X; Zhang G; Rui D; Ju J; Hu Z
    J Clin Microbiol; 2012 Mar; 50(3):646-50. PubMed ID: 22205804
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immunophenotypic patterns of childhood acute leukemias in Indonesia.
    Supriyadi E; Widjajanto PH; Veerman AJ; Purwanto I; Nency YM; Gunawan S; Nafianti S; Purnomosari D; Intansari US; Westra G; Cloos J
    Asian Pac J Cancer Prev; 2011; 12(12):3381-7. PubMed ID: 22471485
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing.
    Rawstron AC; Shingles J; de Tute R; Bennett F; Jack AS; Hillmen P
    Cytometry B Clin Cytom; 2010; 78 Suppl 1():S42-6. PubMed ID: 20839337
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comparative analysis of normal versus CLL B-lymphocytes reveals patient-specific variability in signaling mechanisms controlling LFA-1 activation by chemokines.
    Montresor A; Bolomini-Vittori M; Simon SI; Rigo A; Vinante F; Laudanna C
    Cancer Res; 2009 Dec; 69(24):9281-90. PubMed ID: 19934331
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.